Get started
Author

Krystal A. Orlando

Observed names: Krystal A Orlando, Krystal Ann Orlando, Krystal Orlando, Krystal A Orlando, Orlando, Krystal, Orlando, Krystal A, Orlando, Krystal A., Orlando, Krystal Ann
Observed institutions: University of North Carolina at Chapel Hill, National Institutes of Health, Monmouth University, University of British Columbia, National Institute of Environmental Health Sciences, UNC Lineberger Comprehensive Cancer Center
ORCID: 0000-0001-5790-8843
Observed ORCID: 0000-0001-5790-8843
OpenAlex ID: A5031853152
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines
2020 · Marc Tischkowitz, Sidong Huang, et al. · Clinical Cancer Research · 171
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type
2017 · Yemin Wang, Shary Yuting Chen, et al. · The Journal of Pathology · 105
PDF
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2018 · Yemin Wang, Shary Yuting Chen, et al. · Molecular Cancer Therapeutics · 75
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition
2018 · Jessica D. Lang, William P. D. Hendricks, et al. · Clinical Cancer Research · 72
PDF
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanism
2020 · Krystal Ann Orlando, Amber K Douglas, et al. · eLife · 53
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
2019 · Krystal A Orlando, Vinh Nguyen, et al. · Expert Review of Anticancer Therapy · 52
The estrogen receptor/GATA3/FOXA1 transcriptional network: lessons learned from breast cancer
2021 · Elizabeth M. Martin, Krystal A. Orlando, et al. · Current Opinion in Structural Biology · 43
Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression
2012 · Dennis E. Rhoads, Nicole Grimes, et al. · Pharmacology Biochemistry and Behavior · 25
Sequential Changes in Brain Glutamate and Adenosine A1 Receptors May Explain Severity of Adolescent Alcohol Withdrawal after Consumption of High Levels of Alcohol
2019 · Patrycja Bolewska, Bryan I. Martin, et al. · Neuroscience Journal · 11
PDF
Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling
2025 · Krystal A Orlando, Sara A Grimm, et al. · Nucleic Acids Research · 10
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al. · Cancer Research · 6
Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
2019 · Elizabeth A. Raupach, Krystine Garcia-Mansfield, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 6
PDF
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
2025 · Jessica D. Lang, William Selleck, et al. · iScience · 5
Epigenetic remodelling upon FGFR inhibition
2021 · Krystal A. Orlando, Paul A. Wade · Nature Cell Biology · 2
Abstract B065: Loss of SMARCA4 leads to intron retention and generation of tumor-associated antigens in small cell carcinoma of the ovary, hypercalcemic type
2025 · Elizabeth Raupach, Apurva Hegde, et al. · Cancer Research · 1
Abstract 1459: Selective killing of SMARCA4-deficient gynecologic cancers by mitochondria oxidative phosphorylation inhibitors
2020 · Yemin Wang, Dionzie Ong, et al. · Cancer Research · 1
Abstract LB-038: Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
2020 · Elizabeth Raupach, Krystine Garcia-Mansfield, et al. · Cancer Research · 1
Abstract 4318: Identifying drivers of SMARCA4/BRG1-deficient SCCOHT tumorigenesis by integrative multi-omic analysis
2018 · Krystal A. Orlando, Jesse R. Raab, et al. · Cancer Research · 1
Loss of SMARCA4 leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type.
2026 · Huntsman, David, Lang, Jessica D, et al. · UNC Libraries
Supplementary Materials from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Supplementary Tables from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Data from Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2025 · Elizabeth A. Raupach, Apurva M. Hegde, et al.
Data from Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2023 · Yemin Wang, Shary Yuting Chen, et al.
Data from Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2023 · Yemin Wang, Shary Yuting Chen, et al.
Supplementary Tables S1-S9 from Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
2023 · Yemin Wang, Shary Yuting Chen, et al.
Works count: 54
Citation count: 639
H-index: 10
I10-index: 10
Year
Topic
Type